# Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction

> **NCT04308031** · PHASE3 · UNKNOWN · sponsor: **Chun-Yao Huang** · enrollment: 100 (estimated)

## Conditions studied

- Atrial Fibrillation
- Ivabradine
- Heart Failure

## Interventions

- **DRUG:** Ivabradine 5 mg [Corlanor]
- **DRUG:** Digoxin 0.25 mg

## Key facts

- **NCT ID:** NCT04308031
- **Lead sponsor:** Chun-Yao Huang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-26
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308031, "Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04308031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*